Related Experiment Video
Updated: Aug 15, 2026

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure
Published on: March 20, 2012
Postmarketing surveillance for human teratogenicity: a model approach
C D Chambers1, S R Braddock, G G Briggs
1Department of Pediatrics, University of California, San Diego, CA 92103-8446, USA. chchambers@ucsd.edu
Identifying teratogens requires evaluating patterns of birth defects, not just single malformations. A complementary dysmorphological assessment approach enhances the detection of prenatal exposure risks.
Area of Science:
- Reproductive toxicology
- Developmental biology
- Epidemiology
Background:
- Prenatal exposure to teratogens often results in patterns of major and minor malformations.
- Traditional epidemiological methods struggle to identify new teratogens due to this complexity.
- A novel, complementary approach is needed for comprehensive teratogenicity evaluation.
Purpose of the Study:
- To outline a complementary approach for evaluating prenatal exposures and teratogenicity.
- To enhance the identification of environmental risks during pregnancy.
- To provide a more comprehensive assessment of developmental toxicity.
Main Methods:
- Utilizing a multicenter prospective cohort study design.
- Incorporating dysmorphological assessment of liveborn infants.
- Leveraging the Organization of Teratology Information Services (OTIS) network for research collaboration.
Main Results:
- The focused cohort design enables evaluation of diverse adverse pregnancy outcomes.
- Dysmorphological examinations identify patterns of malformation, a key advantage.
- This method screens for subtle structural anomalies indicative of teratogenic effects.
Conclusions:
- Known human teratogens are associated with patterns of structural defects.
- Combining this approach with traditional methods increases confidence in risk assessment.
- This strategy improves the evaluation of prenatal exposure safety.
More Related Videos
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Mutagenicity and Carcinogenicity
Preclinical Development: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Toxicity Testing in Animals